SZLS.H — StageZero Life Sciences Balance Sheet
0.000.00%
HealthcareAdventurousMicro Cap
Annual balance sheet for StageZero Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2018 December 31st | C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.106 | 0.071 | 6.6 | 1.72 | 0.016 |
| Net Total Receivables | 0.045 | 0.171 | 0.17 | 0.127 | 0.031 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.353 | 0.376 | 7.22 | 2.39 | 0.266 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.07 | 1.04 | 1.26 | 0.872 | 0.434 |
| Net Goodwill | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1.45 | 1.96 | 8.51 | 10.6 | 0.701 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.52 | 4.22 | 5.59 | 4.74 | 7.03 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.96 | 6.46 | 9.74 | 7.88 | 8.2 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -5.51 | -4.49 | -1.23 | 2.76 | -7.5 |
| Total Liabilities & Shareholders' Equity | 1.45 | 1.96 | 8.51 | 10.6 | 0.701 |
| Total Common Shares Outstanding |